Papavassiliou AG - Search Results

1

P53 mutations in stromal fibroblasts sensitize tumors against chemotherapy.

Lafkas D, Trimis G, Papavassiliou AG, Kiaris H. Lafkas D, et al. Among authors: papavassiliou ag. Int J Cancer. 2008 Aug 15;123(4):967-71. doi: 10.1002/ijc.23546. Int J Cancer. 2008. PMID: 18512237

2

Selective modulation of postmenopausal women: cutting the Gordian knot of hormone replacement therapy with breast carcinoma.

Diamanti-Kandarakis E, Sykiotis GP, Papavassiliou AG. Diamanti-Kandarakis E, et al. Among authors: papavassiliou ag. Cancer. 2003 Jan 1;97(1):12-20. doi: 10.1002/cncr.11049. Cancer. 2003. PMID: 12491500 Free article. Review.

3

FK228 (depsipeptide): a HDAC inhibitor with pleiotropic antitumor activities.

Konstantinopoulos PA, Vandoros GP, Papavassiliou AG. Konstantinopoulos PA, et al. Among authors: papavassiliou ag. Cancer Chemother Pharmacol. 2006 Nov;58(5):711-5. doi: 10.1007/s00280-005-0182-5. Epub 2006 Jan 25. Cancer Chemother Pharmacol. 2006. PMID: 16435156 Review.

4

The power and promise of "rewiring" the mitogen-activated protein kinase network in prostate cancer therapeutics.

Papatsoris AG, Karamouzis MV, Papavassiliou AG. Papatsoris AG, et al. Among authors: papavassiliou ag. Mol Cancer Ther. 2007 Mar;6(3):811-9. doi: 10.1158/1535-7163.MCT-06-0610. Mol Cancer Ther. 2007. PMID: 17363478 Review.

5

Deregulated overexpression of hCdt1 and hCdc6 promotes malignant behavior.

Liontos M, Koutsami M, Sideridou M, Evangelou K, Kletsas D, Levy B, Kotsinas A, Nahum O, Zoumpourlis V, Kouloukoussa M, Lygerou Z, Taraviras S, Kittas C, Bartkova J, Papavassiliou AG, Bartek J, Halazonetis TD, Gorgoulis VG. Liontos M, et al. Among authors: papavassiliou ag. Cancer Res. 2007 Nov 15;67(22):10899-909. doi: 10.1158/0008-5472.CAN-07-2837. Cancer Res. 2007. PMID: 18006835

6

The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.

Kotsinas A, Evangelou K, Sideridou M, Kotzamanis G, Constantinides C, Zavras AI, Douglass CW, Papavassiliou AG, Gorgoulis VG. Kotsinas A, et al. Among authors: papavassiliou ag. Cancer Lett. 2008 Feb 8;259(2):177-85. doi: 10.1016/j.canlet.2007.10.013. Epub 2007 Nov 26. Cancer Lett. 2008. PMID: 18037232

7

Expression of p21waf1/Cip1 in stromal fibroblasts of primary breast tumors.

Trimis G, Chatzistamou I, Politi K, Kiaris H, Papavassiliou AG. Trimis G, et al. Among authors: papavassiliou ag. Hum Mol Genet. 2008 Nov 15;17(22):3596-600. doi: 10.1093/hmg/ddn252. Epub 2008 Aug 18. Hum Mol Genet. 2008. PMID: 18713757

8

Essential role of p21/waf1 in the mediation of the anti-proliferative effects of GHRH antagonist JMR-132.

Volakaki AA, Lafkas D, Kassi E, Schally AV, Papavassiliou AG, Kiaris H. Volakaki AA, et al. Among authors: papavassiliou ag. J Mol Endocrinol. 2008 Nov;41(5):389-92. doi: 10.1677/JME-08-0106. Epub 2008 Sep 2. J Mol Endocrinol. 2008. PMID: 18765563

9

Regulation of tumor-stromal fibroblast interactions: implications in anticancer therapy.

Kiaris H, Trimis G, Papavassiliou AG. Kiaris H, et al. Among authors: papavassiliou ag. Curr Med Chem. 2008;15(29):3062-7. doi: 10.2174/092986708786848596. Curr Med Chem. 2008. PMID: 19075653 Review.

10

CHOP-dependent regulation of p21/waf1 during ER stress.

Mihailidou C, Papazian I, Papavassiliou AG, Kiaris H. Mihailidou C, et al. Among authors: papavassiliou ag. Cell Physiol Biochem. 2010;25(6):761-6. doi: 10.1159/000315096. Epub 2010 May 18. Cell Physiol Biochem. 2010. PMID: 20511722 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

536 results

Search Page

Filters